Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACM Research, Inc.ACMR · Entity 3926 | See remarks | December 02, 2025 | December 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACM Research, Inc.
Report date December 02, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-12-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-12-02 · Exercise / conversion · Acquired 100,000 · Balance 100,000 Row 2 · 2025-12-02 · Sale · Disposed 100,000 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.75 to $33.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4. Row 3 · 2025-12-03 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 4 · 2025-12-03 · Sale · Disposed 19,700 · Balance 300 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.51 to $33.48, inclusive. Row 5 · 2025-12-03 · Sale · Disposed 300 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.53 to $33.59, inclusive. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2028-01-24 | Direct | 41,165 |
Reported balance
After 2025-12-02 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-12-02 · Exercise / conversion · Disposed 100,000 · Balance 41,165 F5: The option is fully vested and exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2028-01-24 | Direct | 21,165 |
Reported balance
After 2025-12-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-12-03 · Exercise / conversion · Disposed 20,000 · Balance 21,165 F5: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.75 to $33.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.51 to $33.48, inclusive.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.53 to $33.59, inclusive.
F5: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 03, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 20,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · derivative · entry 7 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,165 Underlying: Class A Common Stock · 20,000 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 300 | $33.57 | $10,071.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · nonDerivative · entry 5 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.53 to $33.59, inclusive. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 19,700 | $33.05 | $651,085.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · nonDerivative · entry 4 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.51 to $33.48, inclusive. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 20,000 | $1.77 | $35,400.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · nonDerivative · entry 3 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · derivative · entry 6 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,165 Underlying: Class A Common Stock · 100,000 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 100,000 | $33.20 | $3,320,000.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · nonDerivative · entry 2 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.75 to $33.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 100,000 | $1.77 | $177,000.00 |
DisclosureSEC source: 0001140361-25-044360 · form4.xml · nonDerivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2024 Filed Sep 24, 2024 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 30,000 | $0.00 Strike: $28.42 | $0.00 |
DisclosureSEC source: 0001140361-24-041747 · form4.xml · derivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2030-07-27 F1 · derivative.exercise_date: On July 28, 2020, the reporting person was granted an option to purchase 30,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable based on the Issuer's satisfaction of certain performance criteria. On September 21, 2024, the Issuer confirmed that certain of the performance criteria were met, resulting in vesting of the option as to 30,000 shares. F1 · balance_after: On July 28, 2020, the reporting person was granted an option to purchase 30,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable based on the Issuer's satisfaction of certain performance criteria. On September 21, 2024, the Issuer confirmed that certain of the performance criteria were met, resulting in vesting of the option as to 30,000 shares. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 8,835 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001140361-23-041326 · form4.xml · derivative · entry 6 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,165 Underlying: Class A Common Stock · 8,835 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was fully vested and exercisable. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 50,001 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-23-041326 · form4.xml · derivative · entry 5 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 50,001 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was fully vested and exercisable. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 46,164 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-23-041326 · form4.xml · derivative · entry 4 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 46,164 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was fully vested and exercisable. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 105,000 | $15.00 | $1,575,000.00 |
DisclosureSEC source: 0001140361-23-041326 · form4.xml · nonDerivative · entry 3 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 8,835 | $1.77 | $15,637.95 |
DisclosureSEC source: 0001140361-23-041326 · form4.xml · nonDerivative · entry 2 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 96,165 | $1.00 | $96,165.00 |
DisclosureSEC source: 0001140361-23-041326 · form4.xml · nonDerivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 23:09 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 13,500 | $0.00 Strike: $25.45 | $0.00 |
DisclosureSEC source: 0001140361-23-000515 · form4.xml · derivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Class A Common Stock · 13,500 shares Expires 2032-03-03 F1 · derivative.exercise_date: On March 4, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable based on the Issuer's satisfaction of certain performance criteria. On December 30, 2022, the Issuer confirmed that certain of the performance criteria were met, resulting in vesting of the option as to 13,500 shares. F1 · balance_after: On March 4, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable based on the Issuer's satisfaction of certain performance criteria. On December 30, 2022, the Issuer confirmed that certain of the performance criteria were met, resulting in vesting of the option as to 13,500 shares. Read SEC document |
| December 30, 2022 Filed Feb 14, 2023 23:18 UTC Amendment | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 3,000 | $0.00 Strike: $25.45 | $0.00 |
DisclosureSEC source: 0001140361-23-007064 · form4.xml · derivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Class A Common Stock · 3,000 shares Expires 2032-03-03 F1 · shares: This Form 4 amendment has been filed solely to correct the number of derivative securities acquired, the amount of underlying securities, and the number of derivative securities beneficially owned following the reported transaction in connection with a previously issued stock option to purchase shares of Class A Common Stock of the Issuer reported in a Form 4 filed on January 4, 2023 (the "Form 4"). Such numbers were inadvertently stated as 13,500 in the Form 4. Such numbers should have been stated as 3,000 in the Form 4. F2 · derivative.exercise_date: On March 4, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable based on the Issuer's satisfaction of certain performance criteria. On December 30, 2022, the Issuer confirmed that certain of the performance criteria were met, resulting in vesting of the option as to 3,000 shares. F1 · derivative.underlying_shares: This Form 4 amendment has been filed solely to correct the number of derivative securities acquired, the amount of underlying securities, and the number of derivative securities beneficially owned following the reported transaction in connection with a previously issued stock option to purchase shares of Class A Common Stock of the Issuer reported in a Form 4 filed on January 4, 2023 (the "Form 4"). Such numbers were inadvertently stated as 13,500 in the Form 4. Such numbers should have been stated as 3,000 in the Form 4. F1 · balance_after: This Form 4 amendment has been filed solely to correct the number of derivative securities acquired, the amount of underlying securities, and the number of derivative securities beneficially owned following the reported transaction in connection with a previously issued stock option to purchase shares of Class A Common Stock of the Issuer reported in a Form 4 filed on January 4, 2023 (the "Form 4"). Such numbers were inadvertently stated as 13,500 in the Form 4. Such numbers should have been stated as 3,000 in the Form 4. F2 · balance_after: On March 4, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable based on the Issuer's satisfaction of certain performance criteria. On December 30, 2022, the Issuer confirmed that certain of the performance criteria were met, resulting in vesting of the option as to 3,000 shares. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $85.27 | $0.00 |
DisclosureSEC source: 0001140361-21-031489 · form4.xml · derivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2030-07-27 F1 · balance_after: On July 28, 2020, the reporting person was granted an option to purchase 20,000 shares of Class A Common Stock of the Issuer. The option vests and becomes exercisable as to 10,000 shares upon the Issuer's receipt of its first demo tool order from a specified semiconductor company and as to the other 10,000 shares, upon the qualification of the Issuer's first demo tool for such semiconductor company. The performance criteria for the first 10,000 shares was met, resulting in vesting of the option as to 10,000 shares. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 22:52 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005065 · form4.xml · derivative · entry 3 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Class A Common Stock · 30,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On February 12, 2021, the reporting person exercised a previously issued stock option to purchase 30,000 shares of Class A Common Stock of the Issuer. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 22:52 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 30,000 | $120.00 | $3,600,000.00 |
DisclosureSEC source: 0001140361-21-005065 · form4.xml · nonDerivative · entry 2 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 22:52 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 30,000 | $3.00 | $90,000.00 |
DisclosureSEC source: 0001140361-21-005065 · form4.xml · nonDerivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On February 12, 2021, the reporting person exercised a previously issued stock option to purchase 30,000 shares of Class A Common Stock of the Issuer. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:35 UTC Amendment | ACM Research, Inc. ACMR · Entity 3926 | Disposition to issuerStock Option · Derivative | 17,946 | $10.20 Strike: $3.00 | $182,959.47 |
DisclosureSEC source: 0001654954-19-011374 · section16.xml · derivative · entry 2 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,388 Underlying: Class A Common Stock · 17,946 shares Expires 2026-12-27 F1 · price: In connection with a public offering of Class A Common Stock by the Issuer, the reporting person and certain other stockholders entered into an Equity Purchase Agreement dated August 4, 2019 pursuant to which the reporting person and such stockholders agreed to sell, and the Issuer agreed to purchase, shares of the Issuer's Class A Common Stock funded by the net proceeds, if any, from the Issuer's sale of Class A Common Stock pursuant to an exercise of the underwriters' over-allotment option. The transaction date for the original Form 4 was August 23, 2019, the date of the closing of the underwriters' over-allotment option and therefore the date on which the obligations of the parties to the Equity Purchase Agreement became fixed and irrevocable. At the time of the filing of the original Form 4, it was contemplated that the reporting person would exercise his rights to purchase 17,946 shares of Class A Common Stock under an outstanding stock option agreement in order to satisfy his obligations under the Equity Purchase Agreement. Subsequent to the filing of the original Form 4, the reporting person and the Issuer agreed that the reporting person would instead satisfy his obligations under the Equity Purchase Agreement by cancelling the reporting person's rights to purchase 17,946 shares of Class A Common Stock under the outstanding stock option agreement. On September 30, 2019, such rights were cancelled in exchange for payment to the reporting person of $182,959.47 in cash, representing the purchase price due to the reporting person pursuant to the Equity Purchase Agreement net of the exercise price attributable to the 17,946 shares cancelled under the reporting person's stock option. F2 · derivative.exercise_date: The option vested and became exercisable as to 8,333 shares on March 1, 2017 and the remaining 25,001 shares vest and become exercisable in equal monthly installments over the following 36 months, subject to continued service through each vesting date. Read SEC document |
| August 23, 2019 Filed Aug 28, 2019 00:40 UTC | ACM Research, Inc. ACMR · Entity 3926 | Disposition to issuerClass A Common Stock | 17,946 | $13.20 | $236,797.47 |
DisclosureSEC source: 0001654954-19-010058 · section16.xml · nonDerivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: In connection with a public offering of Class A Common Stock by the Issuer, the reporting person and certain other stockholders entered into an Equity Purchase Agreement dated August 4, 2019 pursuant to which the reporting person and such stockholders agreed to sell, and the Issuer agreed to purchase, shares of the Issuer's Common Stock funded by the net proceeds, if any, from the Issuer's sale of Class A Common Stock pursuant to an exercise of the underwriters' over-allotment option. The transaction being reported relates to the reporting person's sale under the Equity Purchase Agreement. The obligations of the parties to the Equity Purchase Agreement became fixed and irrevocable as of the transaction date, which is the date of the closing of the underwriters' over-allotment option. F2 · balance_after: The reporting person did not own any outstanding shares of Class A Common Stock as of the transaction date. In order to meet his obligations under the Equity Purchase Agreement, the reporting person expects to exercise, effective as of the date on which he is obligated to sell 17,946 shares of Class A Common Stock to the Issuer under the Equity Purchase Agreement, outstanding options to acquire such 17,946 shares. The reporting person expects to file a subsequent Form 4 in connection with such option exercise. Read SEC document |
| August 04, 2019 Filed Aug 6, 2019 21:14 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001654954-19-008925 · section16.xml · derivative · entry 1 Chen Fuping · CIK 0001729184 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2029-08-03 F1 · derivative.exercise_date: The option will vest and become exercisable as to 2,500 shares on August 4, 2020 and the remaining 7,500 shares will vest and become exercisable in equal monthly installments over the following 36 months, subject to continued service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.